Company Profile
Integra LifeSciences Stock Price, News & Analysis
- Ticker:
- IART
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Integra LifeSciences is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
17.69 USD (+0.51%)
Close
Last updated: June 23, 2026 at 00:00
1.38B USD
Market cap
Why the stock is moving
IART is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Integra LifeSciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Integra LifeSciences is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Integra LifeSciences follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Integra LifeSciences sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Integra LifeSciences Announces Key Executive Appointments
Source: Integra LifeSciences
- 02
Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference
Source: Integra LifeSciences
- 03
Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference
Source: Integra LifeSciences
- 04
Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference
Source: Integra LifeSciences
- 05
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access
Source: Integra LifeSciences
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Integra LifeSciences (IART)?
Integra LifeSciences (IART) most recently closed at 17.69 USD, a +0.51% move versus the previous session.
What is the market cap of Integra LifeSciences (IART)?
Integra LifeSciences currently has a market capitalization of 1.38B USD on BioPharmSignal.
What does Integra LifeSciences do?
Integra LifeSciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is IART stock listed?
Integra LifeSciences (IART) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Integra LifeSciences is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Integra?
Integra LifeSciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Integra LifeSciences targeting with Integra?
Integra LifeSciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is LifeSciences?
Integra LifeSciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.